Evidence map›Paper›PMID 32319424›Full record

ReviewThe American journal of tropical medicine and hygiene2020

Respiratory Support in COVID-19 Patients, with a Focus on Resource-Limited Settings.

Arjen M Dondorp, Muhammad Hayat, Diptesh Aryal, Abi Beane, Marcus J Schultz

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in The American journal of tropical medicine and hygiene, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05083130 (Evaluation of Awake Prone Positioning Effectiveness in Moderate to Severe COVID-19), which is not on this map. Cited by 94 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed, 4 pooled it
24.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05083130 nacompletednot on this mapstarted 2022, after this paper: background citation

Evaluation of Awake Prone Positioning Effectiveness in Moderate to Severe COVID-19

TypeinterventionalSponsorOxford University Clinical Research Unit, VietnamRan2022 to 2023Enrolled93ConditionsCOVID-19, SARS-CoV2 Infection, COVID-19 Acute Respiratory Distress Syndrome, Acute Hypoxemic Respiratory FailureArmsa wake prone positioning
3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 4 syntheses or guidelines pooled it, 209 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Minimizing Societal Cost of Epidemics: Optimal Catastrophe Insurance Compensation Allocation.Risk analysis : an official publication of the Society for Risk Analysis · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Observational
  20. Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 4 countries.

Arjen M DondorpMahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Muhammad HayatDepartment of Anaesthesiology and Surgical Critical Care, Northwest General Hospital & Research Center, Hayatabad Peshawar, Pakistan.
Diptesh AryalDepartment of Critical Care and Anesthesia, Nepal Mediciti Hospital, Lalitpur, Nepal.
Abi BeaneMahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Marcus J SchultzDepartment of Intensive Care, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Mahidol University · THNorthwest General Hospital and Research Center · PKUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ongoing novel coronavirus disease (COVID-19) pandemic is threatening the global human population, including in countries with resource-limited health facilities. Severe bilateral pneumonia is the main feature of severe COVID-19, and adequate ventilatory support is crucial for patient survival. Although our knowledge of the disease is still rapidly increasing, this review summarizes current guidance on the best provision of ventilatory support, with a focus on resource-limited settings. Key messages include that supplemental oxygen is a first essential step for the treatment of severe COVID-19 patients with hypoxemia and should be a primary focus in resource-limited settings where capacity for invasive ventilation is limited. Oxygen delivery can be increased by using a non-rebreathing mask and prone positioning. The presence of only hypoxemia should in general not trigger intubation because hypoxemia is often remarkably well tolerated. Patients with fatigue and at risk for exhaustion, because of respiratory distress, will require invasive ventilation. In these patients, lung protective ventilation is essential. Severe pneumonia in COVID-19 differs in some important aspects from other causes of severe pneumonia or acute respiratory distress syndrome, and limiting the positive end-expiratory pressure level on the ventilator may be important. This ventilation strategy might reduce the currently very high case fatality rate of more than 50% in invasively ventilated COVID-19 patients.

Indexed as

PandemicsAdenosine MonophosphateAlanineBetacoronavirusChloroquineContinuous Positive Airway PressureCoronavirus InfectionsCOVID-19Developing CountriesDisease ManagementHumansHydroxychloroquineLopinavirLungOxygenPneumonia, ViralAdenosine MonophosphateAlanineChloroquineHydroxychloroquineLopinavirOxygenremdesivirRitonavir

Identifiers

PMID32319424
PMCPMC7253105
OpenAlexW3016910743

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.